11/19
05:17 pm
qlgn
Form SCHEDULE 13D/A Qualigen Therapeutics, Filed by: FARADAY FUTURE INTELLIGENT ELECTRIC INC.
Neutral
Report
Form SCHEDULE 13D/A Qualigen Therapeutics, Filed by: FARADAY FUTURE INTELLIGENT ELECTRIC INC.
11/17
06:10 am
qlgn
Form 8-K Qualigen Therapeutics, For: Nov 12
Medium
Report
Form 8-K Qualigen Therapeutics, For: Nov 12
11/14
05:16 pm
qlgn
Form 10-Q Qualigen Therapeutics, For: Sep 30
High
Report
Form 10-Q Qualigen Therapeutics, For: Sep 30
11/12
09:33 pm
qlgn
Form SCHEDULE 13D Qualigen Therapeutics, Filed by: FARADAY FUTURE INTELLIGENT ELECTRIC INC.
High
Report
Form SCHEDULE 13D Qualigen Therapeutics, Filed by: FARADAY FUTURE INTELLIGENT ELECTRIC INC.
11/12
05:18 pm
qlgn
Form SCHEDULE 13G/A Qualigen Therapeutics, Filed by: ALPHA CAPITAL ANSTALT
Medium
Report
Form SCHEDULE 13G/A Qualigen Therapeutics, Filed by: ALPHA CAPITAL ANSTALT
10/20
05:29 pm
qlgn
Form DEF 14A Qualigen Therapeutics, For: Oct 20
Low
Report
Form DEF 14A Qualigen Therapeutics, For: Oct 20
10/10
05:15 pm
qlgn
Form PRE 14A Qualigen Therapeutics, For: Oct 10
Medium
Report
Form PRE 14A Qualigen Therapeutics, For: Oct 10
10/7
06:02 am
qlgn
Form 8-K Qualigen Therapeutics, For: Oct 01
Low
Report
Form 8-K Qualigen Therapeutics, For: Oct 01
10/3
05:27 pm
qlgn
Form 8-K Qualigen Therapeutics, For: Sep 29
Medium
Report
Form 8-K Qualigen Therapeutics, For: Sep 29
9/29
06:04 am
qlgn
Form 8-K Qualigen Therapeutics, For: Sep 26
Medium
Report
Form 8-K Qualigen Therapeutics, For: Sep 26
9/29
06:03 am
qlgn
Form EFFECT Qualigen Therapeutics,
Medium
Report
Form EFFECT Qualigen Therapeutics,
9/25
05:06 pm
qlgn
Form 8-K Qualigen Therapeutics, For: Sep 19
Medium
Report
Form 8-K Qualigen Therapeutics, For: Sep 19
9/24
04:30 pm
qlgn
Form RW Qualigen Therapeutics,
High
Report
Form RW Qualigen Therapeutics,
9/16
04:34 pm
qlgn
Form S-1 Qualigen Therapeutics,
High
Report
Form S-1 Qualigen Therapeutics,
9/16
09:46 am
qlgn
Form 8-K Qualigen Therapeutics, For: Sep 15
Low
Report
Form 8-K Qualigen Therapeutics, For: Sep 15
9/8
04:31 pm
qlgn
Form 8-K Qualigen Therapeutics, For: Sep 04
Low
Report
Form 8-K Qualigen Therapeutics, For: Sep 04